Market Dynamics:
Leishmaniasis predominantly occurs in tropical and sub-tropical regions and the lack of awareness about it in disease-endemic areas is one of the key factors driving research activities. Increased research initiatives by public and private organizations for development of novel and effective drugs is propelling market growth. For instance, iCo Therapeutics, Merck and AEterna Zentaris are involved in clinical trials for new drug formulations to treat leishmaniasis. Additionally, the rising prevalence of leishmaniasis worldwide due to factors such as increasing international travel and migration, environmental changes and lack of vector control measures is facilitating the market expansion.

Key Takeaways

The Global Leishmaniasis Treatment Market Size is expected to witness high growth, exhibiting CAGR of 17% over the forecast period, due to increasing prevalence of leishmaniasis infections worldwide. As per the World Health Organization (WHO), annually 1.3 million new cases and more than 20,000-30,000 deaths are reported due to leishmaniasis globally.

For More Insights, Read: https://newsinsights123.blogspot.com/2023/12/telemedicine-is-fastest-growing-segment.html